Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-02-14 09:43 am Purchase | 13G | THERAVANCE BIOPHARMA INC TBPH | Madison Avenue Partners LP | 6,648,025 9% | 2,080,612 (+45.55%) | View |
| 2022-02-11 4:49 pm Sale | 13G | THERAVANCE BIOPHARMA INC TBPH | ORBIMED ADVISORS LLC | 5,456,780 7.4% | -87,432 (-1.58%) | View |
| 2022-02-11 4:15 pm Purchase | 13G | THERAVANCE BIOPHARMA INC TBPH | BAUPOST GROUP LLC | 14,530,996 19.49% | 4,925,000 (+51.27%) | View |
| 2022-02-10 4:48 pm Unchanged | 13D | THERAVANCE BIOPHARMA INC TBPH | GSK plc GSK | 9,644,807 13.1% | 0 (Unchanged) | View |
| 2022-02-10 08:42 am Purchase | 13G | THERAVANCE BIOPHARMA INC TBPH | VANGUARD GROUP INC | 6,299,823 8.55% | 1,645,514 (+35.35%) | View |
| 2022-02-03 4:29 pm Purchase | 13G | THERAVANCE BIOPHARMA INC TBPH | BlackRock Inc. BLK | 5,002,363 6.8% | 511,168 (+11.38%) | View |
| 2021-10-12 09:25 am Sale | 13G | THERAVANCE BIOPHARMA INC TBPH | FMR LLC | 2,670,881 3.635% | -6,936,429 (-72.20%) | View |
| 2021-10-08 08:36 am Sale | 13G | THERAVANCE BIOPHARMA INC TBPH | WELLINGTON MANAGEMENT GROUP LLP | 250,219 0.34% | -7,352,526 (-96.71%) | View |
| 2021-09-27 4:46 pm Purchase | 13G | THERAVANCE BIOPHARMA INC TBPH | Madison Avenue Partners LP | 4,567,413 6.2% | 4,567,413 (New Position) | View |
| 2021-09-07 4:35 pm Purchase | 13G | THERAVANCE BIOPHARMA INC TBPH | Point72 Asset Management L.P. | 5,144,637 7% | 5,144,637 (New Position) | View |
| 2021-04-12 08:02 am Purchase | 13G | THERAVANCE BIOPHARMA INC TBPH | WELLINGTON MANAGEMENT GROUP LLP | 7,602,745 11.66% | 1,993,118 (+35.53%) | View |
| 2021-02-12 5:10 pm Purchase | 13G | THERAVANCE BIOPHARMA INC TBPH | ORBIMED ADVISORS LLC | 5,544,212 8.67% | 5,544,212 (New Position) | View |
| 2021-02-12 4:26 pm Sale | 13G | THERAVANCE BIOPHARMA INC TBPH | BAUPOST GROUP LLC | 9,605,996 14.81% | -574,000 (-5.64%) | View |
| 2021-02-10 11:57 am Purchase | 13G | THERAVANCE BIOPHARMA INC TBPH | VANGUARD GROUP INC | 4,654,309 7.27% | 650,707 (+16.25%) | View |
| 2021-02-08 10:33 am Purchase | 13G | THERAVANCE BIOPHARMA INC TBPH | FMR LLC | 9,607,310 15% | 1,083,137 (+12.71%) | View |
| 2021-02-05 08:03 am Purchase | 13G | THERAVANCE BIOPHARMA INC TBPH | BlackRock Inc. BLK | 4,491,195 7% | 113,268 (+2.59%) | View |
| 2021-02-03 1:22 pm Purchase | 13G | THERAVANCE BIOPHARMA INC TBPH | WELLINGTON MANAGEMENT GROUP LLP | 5,609,627 8.77% | 2,432,090 (+76.54%) | View |
| 2020-07-10 10:48 am Sale | 13G | THERAVANCE BIOPHARMA INC TBPH | BlackRock Inc. BLK | 4,377,927 6.9% | -4,304,752 (-49.58%) | View |
| 2020-06-23 4:21 pm Sale | 13G | THERAVANCE BIOPHARMA INC TBPH | Link Fund Solutions Ltd | 0 0% | -5,251,349 (Position Closed) | View |
| 2020-06-22 5:13 pm Unchanged | 13D | THERAVANCE BIOPHARMA INC TBPH | GSK plc GSK | 9,644,807 15.3% | 0 (Unchanged) | View |